PT Kalbe Farma Tbk. (KLBF.JK)
Makes and distributes medicines, vitamins, and health products across Indonesia.
700.00+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-51.0%
The outlook
KLBF.JK is trading near its 52-week lows with analysts showing strong buy consensus and an average price target roughly 79% above the current level. The stock sits below both its 50- and 200-day moving averages, signaling a weak near-term trend despite the bullish analyst outlook. At a trailing P/E of 8.8, valuations appear compressed relative to analyst expectations.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 17 analysts
Price trendBelow its 50- & 200-day averages
52-week range8% of the way from its 52-week low to high
Price targetAvg target +79% vs current price
Analyst price target
~12-month · 17 analysts1,254.12average target+79.2% vs now
Now 700.00
Low 820.00High 1,700.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$31.67T
52-wk high
1,510.00
52-wk low
630.00
50-day avg
747.80
200-day avg
1,013.43
Trailing P/E
8.8